Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Rajavelu Esther
See Remarks at Spero Therapeutics. Filing since 7 Nov 2024.
CIK 0001903716
Company
Date
Role
Action
Shares
Amount
Of holding
SPRO
Spero Therapeutics, Inc.
4 May 2026
See Remarks
Sold at will
25,240
$63.35K
2.5%
SPRO
Spero Therapeutics, Inc.
6 Feb 2026
See Remarks
Sold at will
87,917
$207.48K
8.0%
SPRO
Spero Therapeutics, Inc.
2 Feb 2026
See Remarks
Sold at will
18,442
$40.57K
1.6%
SPRO
Spero Therapeutics, Inc.
7 Nov 2025
See Remarks
Sold at will
40,270
$95.44K
4.4%
SPRO
Spero Therapeutics, Inc.
5 Feb 2025
CFO & CBO
Sold at will
20,689
$16.14K
2.8%
SPRO
Spero Therapeutics, Inc.
8 Nov 2024
CFO & CBO
Sold at will
17,245
$22.42K
4.3%
SPRO
Spero Therapeutics, Inc.
7 Nov 2024
CFO & CBO
Sold at will
23,351
$30.59K
5.6%
7 decisions on file.
